PAR 1.69% 29.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-11

  1. 2,149 Posts.
    lightbulb Created with Sketch. 802
    The 3.8 quarters is misleading, it’s the equation of current balance by the previous quarterly outflow of $6.8m.
    $26.2m by $6.8m = 3.8
    But as we know the $7.3m RnD refund is not included otherwise our runway would calculate as 1.8 quarters left of cash.
    Current quarter spend estimate is $7m - $10m, let’s go middle ground of $8.5m, that would leave $6.3m for each quarter of the remaining 2.8 quarters.

    Basically what I’m saying is those forward quarterly estimates can be taken with a gain of salt as they are not actual forward cash projections.

    I prefer to just go with the commentary, at the end of this quarter we should have $16m cash worst case if they keep to guidance.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.0¢
Change
-0.005(1.69%)
Mkt cap ! $101.4M
Open High Low Value Volume
29.5¢ 30.0¢ 29.0¢ $40.16K 137.1K

Buyers (Bids)

No. Vol. Price($)
5 66491 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 33118 1
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.